These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38194765)

  • 1. Trends and the associated factors of optimal immunological response and virological response in late anti-retroviral therapy initiation HIV cases in Taiwan from 2009 to 2020.
    Lee CY; Lin YP; Lin CY; Chen TC; Kuo SH; Lo SH; Wang SF; Lu PL
    J Infect Public Health; 2024 Feb; 17(2):339-348. PubMed ID: 38194765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan.
    Lee YC; Hung CC; Tsai MS; Zhang JY; Wu PY; Yang SP; Luo YZ; Chang HY; Liu WC; Sun HY; Chang SC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):38-44. PubMed ID: 27329131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen.
    Armenia D; Di Carlo D; Cozzi-Lepri A; Calcagno A; Borghi V; Gori C; Bertoli A; Gennari W; Bellagamba R; Castagna A; Latini A; Pinnetti C; Cicalini S; Saracino A; Lapadula G; Rusconi S; Castelli F; Di Giambenedetto S; Andreoni M; Di Perri G; Antinori A; Mussini C; Ceccherini-Silberstein F; Monforte AD; Perno CF; Santoro MM;
    Antivir Ther; 2019; 24(5):321-331. PubMed ID: 30977466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up.
    Lin KY; Cheng CY; Li CW; Yang CJ; Tsai MS; Liu CE; Lee YT; Tang HJ; Wang NC; Lin TY; Lee YC; Lin SP; Huang YS; Zhang JY; Ko WC; Cheng SH; Hung CC;
    PLoS One; 2017; 12(6):e0179870. PubMed ID: 28665938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir.
    Abgrall S; Yeni PG; Bouchaud O; Costagliola D;
    AIDS; 2006 Oct; 20(16):2099-106. PubMed ID: 17053356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.
    Tuboi SH; Brinkhof MW; Egger M; Stone RA; Braitstein P; Nash D; Sprinz E; Dabis F; Harrison LH; Schechter M
    J Acquir Immune Defic Syndr; 2007 May; 45(1):52-9. PubMed ID: 17460471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS-related opportunistic illnesses and early initiation of HIV care remain critical in the contemporary HAART era: a retrospective cohort study in Taiwan.
    Lee CY; Tseng YT; Lin WR; Chen YH; Tsai JJ; Wang WH; Lu PL; Tsai HC
    BMC Infect Dis; 2018 Jul; 18(1):352. PubMed ID: 30055564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study.
    Hughes RA; Sterne JA; Walsh J; Bansi L; Gilson R; Orkin C; Hill T; Ainsworth J; Anderson J; Gompels M; Dunn D; Johnson MA; Phillips AN; Pillay D; Leen C; Easterbrook P; Gazzard B; Fisher M; Sabin CA
    HIV Med; 2011 Nov; 12(10):583-93. PubMed ID: 21569188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An observational study of initial HIV RNA decay following initiation of combination antiretroviral treatment during pregnancy.
    Alagaratnam J; Peters H; Francis K; Kay N; Gilleece Y; Finnerty FP; Grimes RE; Parry S; Portman M; Wait BC; Shah R; Roedling S; Hawkins DA; Chitty S; Sarner L; Marcus R; Hartley A; Nori AV; Rosenvinge M; Taylor GP;
    AIDS Res Ther; 2020 Jul; 17(1):41. PubMed ID: 32660502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
    ; Judd A; Chappell E; Turkova A; Le Coeur S; Noguera-Julian A; Goetghebuer T; Doerholt K; Galli L; Pajkrt D; Marques L; Collins IJ; Gibb DM; González Tome MI; Navarro M; Warszawski J; Königs C; Spoulou V; Prata F; Chiappini E; Naver L; Giaquinto C; Thorne C; Marczynska M; Okhonskaia L; Posfay-Barbe K; Ounchanum P; Techakunakorn P; Kiseleva G; Malyuta R; Volokha A; Ene L; Goodall R
    PLoS Med; 2018 Jan; 15(1):e1002491. PubMed ID: 29381702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand.
    European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) and Early-treated Perinatally HIV-infected Individuals: Improving Childrenʼs Actual Life with Novel Immunotherapeutic Strategies (EPIICAL) study groups
    AIDS; 2019 Jun; 33(7):1155-1165. PubMed ID: 30741823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
    Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
    AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4/CD8 Ratio Recovery of Children and Adolescents Living With HIV With Virological Suppression: A Prospective Cohort Study.
    Han WM; Apornpong T; Handoko R; Jantarabenjakul W; Gatechompol S; Ubolyam S; Kerr SJ; Avihingsanon A; Ruxrungtham K; Phanuphak P; Puthanakit T
    J Pediatric Infect Dis Soc; 2021 Mar; 10(2):88-96. PubMed ID: 32188991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.
    Karo B; Krause G; Castell S; Kollan C; Hamouda O; Haas W;
    BMC Infect Dis; 2017 Jul; 17(1):517. PubMed ID: 28743248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia.
    Hailu GG; Wasihun AG
    BMC Infect Dis; 2021 Jun; 21(1):561. PubMed ID: 34118891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.
    Cingolani A; Cozzi Lepri A; Castagna A; Goletti D; De Luca A; Scarpellini P; Fanti I; Antinori A; d'Arminio Monforte A; Girardi E
    Clin Infect Dis; 2012 Mar; 54(6):853-61. PubMed ID: 22157323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):772-81. PubMed ID: 27030657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late cART Initiation Consistently Driven by Late HIV Presentation: A Multicenter Retrospective Cohort Study in Taiwan from 2009 to 2019.
    Lee CY; Lin YP; Wang SF; Lu PL
    Infect Dis Ther; 2022 Jun; 11(3):1033-1056. PubMed ID: 35301666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.